Altered circulating miRNA expression profile in pregestational and gestational obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 11, 2015, Pages E1446-E1456

  Carreras Badosa, Gemma ^a,c   Bonmatí, Alexandra ^b   Ortega, Francisco Jose ^a,d,e   Mercader, Josep Maria ^f   Guindo Martínez, Marta ^f   Torrents, David ^f,g   Prats Puig, Anna ^a   Martinez Calcerrada, Jose Maria ^f,h   Platero Gutierrez, Estíbaliz ^a,c   De Zegher, Francis ⁱ   Ibáñez, Lourdes ^j   Fernandez Real, Jose Manuel ^a,d,e   Lopez Bermejo, Abel ^a,c   Bassols, Judit ^a,c  

^a UNIVERSITY OF GIRONA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f BARCELONA SUPERCOMPUTING CENTER   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h Institute of Legal Medicine of Catalonia   (Spain)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

^j UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; BIRTH WEIGHT; BLOOD; BODY MASS; CHILD DEVELOPMENT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; FETUS DEVELOPMENT; FOLLOW UP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; MATERNAL NUTRITION; METABOLISM; NEWBORN; OBESITY; PREGNANCY; PREGNANCY COMPLICATION; REPRODUCTION; SECOND TRIMESTER PREGNANCY; SPAIN; VALIDATION STUDY; WEIGHT GAIN;

ADULT; BIOMARKERS; BIRTH WEIGHT; BODY MASS INDEX; CHILD DEVELOPMENT; CROSS-SECTIONAL STUDIES; FEMALE; FETAL DEVELOPMENT; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT, NEWBORN; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICRORNAS; OBESITY; PLACENTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; SPAIN; WEIGHT GAIN;

EID: 84958632985     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2872     Document Type: Article

References (40)

1. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9(suppl 4):228S-233S.
2. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290-e296.
3. Oken E, Rifas-Shiman SL, Field AE, Frazier AL, Gillman MW. Maternal gestational weight gain and offspring weight in adolescence. Obstet Gynecol. 2008;112:999-1006.
4. Armitage JA, Poston L, Taylor PD. Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front Horm Res. 2008;36:73-84.
5. Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics. 2004;114:e29-e36.
6. Lillycrop KA, Burdge GC. Epigenetic changes in early life and future risk of obesity. Int J Obes (Lond). 2011;35:72-83.
7. Nicholas LM, Rattanatray L, MacLaughlin SM, et al. Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring. FASEB J. 2013;27:3786-3796.
8. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835-840.
9. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455:64-71.
10. Du T, Zamore PD. Beginning to understand microRNA function. Cell Res. 2007;17:661-663.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
12. Chen X, Ba Y,MaL, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006.
13. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA. 2009;106:4402-4407.
14. Li H, Ge Q, Guo L, Lu Z. Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int. 2013;2013:970265.
15. Xu P, Zhao Y, Liu M, et al. Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension. 2014;63:1276-1284.
16. Hromadnikova I, Kotlabova K, Ondrackova M, et al. Circulating C19MCmicroRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm. 2013;2013:186041.
17. Ge Q, Zhu Y, Li H, Tian F, Xie X, Bai Y. Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomia. Int J Mol Med. 2015;35:81-91.
18. Zhu S, Cao L, Zhu J, et al. Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Clin Chim Acta. 2013;424:66-72.
19. OlsonCM.Achieving a healthy weight gain during pregnancy.Annu Rev Nutr. 2008;28:411-423.
20. Prats-Puig A, Ortega FJ, Mercader JM, et al. Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab. 2013;98:E1655-E1660.
21. Ortega FJ, Mercader JM, Catalan V, et al. Targeting the circulating microRNA signature of obesity. Clin Chem. 2013;59:781-792.
22. Vandesompele J,DePreter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3: RESEARCH0034.
23. Chartoumpekis DV, Zaravinos A, Ziros PG, et al. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One. 2012;7:e34872.
24. Murri M, Insenser M, Fernandez-Duran E, San-Millan JL, Escobar-Morreale HF. Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. J Clin Endocrinol Metab. 2013;98:E1835-E1844.
25. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011;474:649-653.
26. Kim C, Lee H, Cho YM, Kwon OJ, Kim W, Lee EK. TNFα-induced miR-130 resulted in adipocyte dysfunction during obesity-related inflammation. FEBS Lett. 2013;587:3853-3858.
27. Chou WW, Wang YT, Liao YC, Chuang SC, Wang SN, Juo SH. Decreased microRNA-221 is associated with high levels of TNF-α in human adipose tissue-derived mesenchymal stem cells from obese woman. Cell Physiol Biochem. 2013;32:127-137.
28. Dharap A, Pokrzywa C, Murali S, Pandi G, Vemuganti R. MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS One. 2013;8:e79467.
29. Roderburg C, Mollnow T, Bongaerts B, et al. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One. 2012;7:e32999.
30. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006; 3:87-98.
31. Li Y, Song YH, Li F, Yang T, Lu YW, Geng YJ. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun. 2009;381:81-83.
32. Abbas A, Grant PJ, KearneyMT.Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Rev Cardiovasc Ther. 2008;6: 1135-1149.
33. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432:226-230.
34. Ortega FJ, Mercader JM, Moreno-Navarrete JM, et al. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014;37:1375-1383.
35. O'Tierney-Ginn P, Presley L, Myers S, Catalano P. Placental growth response to maternal insulin in early pregnancy. J Clin Endocrinol Metab. 2015;100:159-165.
36. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol. 2007;21: 2785-2794.
37. Wessels JM, Edwards AK, Khalaj K, Kridli RT, Bidarimath M, Tayade C. The microRNAome of pregnancy: deciphering miRNA networks at the maternal-fetal interface. PLoS One. 2013;8:e72264.
38. Liu N, Tang LL, Sun Y, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett. 2013;329:181-188.
39. Adlakha YK, Saini N. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer. 2014;13:33.
40. He XX, Guo AY, Xu CR, et al. Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. Oncol Rep. 2014;32:1200-1210.